Non-pegylated long-circulating liposomes

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/127 (2006.01) A61K 9/133 (2006.01) A61K 31/704 (2006.01)

Patent

CA 2511464

The present invention provides a long circulating non-pegylated liposomal doxorubicin composition for parenteral administration and a process for its preparation. The circulation time in swiss albino mice is at least 25 times longer than conventional non-liposomal compositions. The non-pegylated liposomes are stable, exhibit low toxicity and have been found to be efficacious in different tumor models.

L'invention concerne une composition de doxorubicine liposomale non PEG pour une administration parentérale et un procédé pour sa préparation. La durée de circulation dans des souris Swiss/albino est d'au moins 25 fois plus longue que celle de compositions non liposomales classiques. Les liposomes non PEG sont stables, présentent une faible toxicité et s'avèrent efficaces dans différents modèles de tumeurs.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Non-pegylated long-circulating liposomes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Non-pegylated long-circulating liposomes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-pegylated long-circulating liposomes will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1905030

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.